Please assess the completion status of the following clinical trial:

Trial Title: The Intracerebral Hemorrhage Acutely Decreasing Arterial Pressure Trial II

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age ≥18 years~* Acute primary ICH demonstrated with CT scan, within 6 h of symptom onset.~* Two systolic BP measurements ≥140 mmHg recorded \>2 min apart to qualify for enrolment.~* Onset ≤ 24 h prior to randomization~Exclusion Criteria:~* Contraindication to BP reduction i.e., severe arterial stenosis or high-grade stenotic valvular heart disease~* Indication for urgent BP reduction i.e., hypertensive encephalopathy, or aortic dissection~* Definite evidence that the ICH is secondary to underlying cerebral or vascular pathology, i.e., AVM, aneurysm, tumour, trauma, vasculitis, or hemorrhagic transformation of an ischemic infarct~* Previous ischemic stroke within 90 days of current event NB: Prior ICH is not an exclusion criterion~* Patients with suspected secondary cause of ICH.~* Planned surgical resection of hematoma NB: Extraventricular Drain placement is not an exclusion criterion~* Contraindication to CT perfusion imaging (i.e. contrast allergy, metformin use or Creatinine \>160 μmol/l)~* Patients with pre-existing disability and dependence (defined as a pre-morbid modified Rankin Scale score ≥3) will be excluded~* Patients with life expectancy \<6 months due to pre-morbid conditions/terminal illness~* Patients with known definite contraindications to MRI (pacemaker, ferrous metallic foreign body)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Target systolic BP <140mmHg (Type: EXPERIMENTAL): Systolic blood pressure will be reduced to \<140 mmHg within 1 hour of randomization.
- Target systolic BP <180mmHg (Type: ACTIVE_COMPARATOR): Systolic blood pressure will be reduced, to \<180 mmHg within 1 hour of randomization.

Based on this trial design, predict the completion outcome and termination type (if applicable).